GlassScriptPhysician profile
Tara Mccann
NPI 1497196364
$1,751.89
in general payments reported to CMS, 2019-2025
28 companies · $321 in 2025
The $321 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $113 · 2021: $335 · 2022: $334 · 2023: $181 · 2024: $264 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $381.74 | 2019-2025 | |
| Amgen INC. | $159.55 | 2019-2022 | |
| Sage Therapeutics, LLC | $154.74 | 2022-2025 | Zurzuvae |
| Mylan Pharmaceuticals INC. | $101.70 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $100.67 | 2021-2025 | |
| Shield Therapeutics INC | $85.33 | 2023-2024 | Accrufer |
| Daiichi Sankyo INC. | $81.91 | 2021-2022 | |
| Astellas Pharma US INC | $67.67 | 2025 | Veozah |
| Myovant Sciences INC. | $60.41 | 2021-2022 | |
| Therapeuticsmd, INC. | $57.77 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $54.75 | 2024-2025 | Myfembree, Gemtesa |
| Evofem Biosciences, INC. | $53.63 | 2021-2022 | |
| Organon LLC | $50.75 | 2023-2024 | Nexplanon |
| Pfizer INC. | $38.55 | 2024 | |
| Millicent US INC | $34.99 | 2025 | Intrarosa, Femring, Femlyv |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $34.96 | 2024-2025 | Slynd |
| Baxter Healthcare | $31.94 | 2024 | Tisseel |
| Aspira Women'S Health INC | $28.82 | 2021 | |
| Supernus Pharmaceuticals, INC. | $24.61 | 2025 | Qelbree |
| Exact Sciences Corporation | $22.28 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $22.25 | 2021 | |
| Medtronic, INC. | $18.99 | 2022 | |
| Duchesnay USA Incorporated | $16.07 | 2019 | |
| Coopersurgical, INC. | $14.64 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.14 | 2019 | |
| Avion Pharmaceuticals | $13.66 | 2022 | |
| Scynexis, INC. | $13.36 | 2022 | |
| Vertical Pharmaceuticals, LLC | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Mccann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.